Bortezomib in Anti-Cancer Activity: A Potential Drug
Journal Title: Global Journal of Cancer Therapy - Year 2016, Vol 2, Issue 1
Abstract
26S proteasome is an intracellular; ATP dependent enzymatic complex degrades ubiquitin-tagged proteins and maintains cellular homeostasis. The orderly degraded proteins including cyclins, caspases, Bcl-xL, p53, cell adhesion molecules are involved in cell-cycle progression, tumor suppression, DNA replication, inflammation, and apoptosis. So, proteasome inhibition is a target therapy for cancer to promote cell cycle arrest or apoptosis. Bortezomib (Velcade®, PS-341, and Millennium Pharmaceuticals, Inc.) is the first, selective, reversible, and only proteasome inhibitor for the treatment of multiple myeloma have been approved by U.S. Food and Drug Administration (FDA) in 2003. Bortezomib downregulates the interaction of multiple myeloma cells with bone marrow stromal cells, inhibits angiogenesis, and blocks cell cycle progression. Clinically, continuous dosage of bortezomib leads to few side effects.
Authors and Affiliations
Appavu Rajagopal, Mohan Deepa
Keywords
Related Articles
- EP ID EP352840
- DOI 10.17352/2581-5407.000007
- Views 101
- Downloads 0
The Paradoxes of Neoantigenes in Predicting Better Prognosis of Cancer Patients
Increased neoantigens of cancer generated by mutations are reported to be associated with favorable prognosis of cancer patients. The interesting findings contradict the notions that cancers were caused by accumulation o...
The Promise of Disease Management in Greece
Background: Disease Management (DM) is an approach to health care that coordinates resources across the entire health care delivery system and throughout the course of a disease. Objectives: The purpose of the present s...
Total Oncology is necessary for Japanese new era
Still in Japan, medical oncologists need to play a main role and work a lot of tasks by themselves in cancer chemotherapy. The situation of cancer chemotherapy has progressed day by day and considering the current enviro...
Primary Spindle Cell Rhabdomyosarcoma of Prostate: A Case Report with Review of Literature
Primary spindle cell rhabdomyosarcoma of the prostate is an uncommon variant of embryonal rhabdomyosarcoma seen in pediatric age group mostly during infancy and childhood. Rhabdomyosarcoma (RMS) arising from prostate pre...
Financial Crisis and Health
The financial crisis has a dramatic impact on social life, since reduced or even non-existent incomes affect people’s well-being and push big parts of the population to poverty. The individuals’ financial status affects...